Själander A - Search Results

1

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.

Wieloch M, Själander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ. Wieloch M, et al. Among authors: sjalander a. Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26. Eur Heart J. 2011. PMID: 21616951

2

Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population.

Själander A, Engström G, Berntorp E, Svensson P. Själander A, et al. J Intern Med. 2003 Nov;254(5):434-8. doi: 10.1046/j.1365-2796.2003.01209.x. J Intern Med. 2003. PMID: 14535964

3

Menorrhagia and minor bleeding symptoms in women on oral anticoagulation.

Själander A, Friberg B, Svensson P, Stigendal L, Lethagen S. Själander A, et al. J Thromb Thrombolysis. 2007 Aug;24(1):39-41. doi: 10.1007/s11239-006-0003-7. Epub 2007 Jan 27. J Thromb Thrombolysis. 2007. PMID: 17260163

4

Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.

Wallvik J, Själander A, Johansson L, Bjuhr O, Jansson JH. Wallvik J, et al. Among authors: sjalander a. Scand J Prim Health Care. 2007 Jun;25(2):123-8. doi: 10.1080/02813430601183108. Scand J Prim Health Care. 2007. PMID: 17497491 Free PMC article.

5

Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis.

Själander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P. Själander A, et al. J Intern Med. 2008 Jan;263(1):52-60. doi: 10.1111/j.1365-2796.2007.01878.x. J Intern Med. 2008. PMID: 18088252 Review.

6

[Guidelines for anticoagulation in patients with valve prosthesis. More supposition than scientific evidence].

Själander A, Jeppsson A, Svensson PJ. Själander A, et al. Lakartidningen. 2010 Sep 29-Oct 5;107(39):2326-8. Lakartidningen. 2010. PMID: 20973249 Review. Swedish. No abstract available.

7

Computerised assistance for warfarin dosage--effects on treatment quality.

Dimberg I, Grzymala-Lubanski B, Hägerfelth A, Rosenqvist M, Svensson P, Själander A. Dimberg I, et al. Among authors: sjalander a. Eur J Intern Med. 2012 Dec;23(8):742-4. doi: 10.1016/j.ejim.2012.07.011. Epub 2012 Aug 20. Eur J Intern Med. 2012. PMID: 22917757

8

Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.

Grzymala-Lubanski B, Själander S, Renlund H, Svensson PJ, Själander A. Grzymala-Lubanski B, et al. Among authors: sjalander s, sjalander a. Thromb Res. 2013 Feb;131(2):130-4. doi: 10.1016/j.thromres.2012.11.016. Epub 2012 Dec 8. Thromb Res. 2013. PMID: 23232091

9

Estimated glomerular filtration rate is associated with major bleeding complications but not thromboembolic events, in anticoagulated patients taking warfarin.

Wieloch M, Jönsson KM, Själander A, Lip GY, Eriksson N, Svensson PJ. Wieloch M, et al. Among authors: sjalander a. Thromb Res. 2013 Jun;131(6):481-6. doi: 10.1016/j.thromres.2013.01.006. Epub 2013 Jan 23. Thromb Res. 2013. PMID: 23351664

10

Atrial fibrillation patients do not benefit from acetylsalicylic acid.

Själander S, Själander A, Svensson PJ, Friberg L. Själander S, et al. Among authors: sjalander a. Europace. 2014 May;16(5):631-8. doi: 10.1093/europace/eut333. Epub 2013 Oct 24. Europace. 2014. PMID: 24158253

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results